What can a diagnostics company do for antimicrobial stewardship?
Dr. François Lacoste, Executive Vice President, Clinical Unit, bioMérieux, was recently...
Read More
VITEK® MS
Recent FDA clearances bring important breakthroughs to US market
Regulatory approvals, as you are aware, are an important step in bringing products to market. A...
Read More
Who’s afraid of Candida auris?
bioMérieux steps in to meet new identification needs.
New species of pathogens that can cause more severe infections and exhibit greater resistance to...
Read More
VITEK® MS: First MALDI-TOF system with IVD-CE marked ID of mycobacteria, Nocardia & moulds*
The latest VITEK® MS software update includes a database for the identification of...
Read More
LEARN MORE ON BACT/ALERT® VIRTUO®
LEARN MORE ON VITEK® 2
